Sep 19, 2012 | Recent Deals | San Francisco
O’Melveny & Myers LLP represented China-based BGI-Shenzhen, a leading international genomics company, in entering into a definitive merger agreement with Complete Genomics, Inc. The transaction is valued at approximately US$117.6 million.
The O’Melveny team was led by San Francisco-based partner Paul Scrivano and Shanghai-based counsel Wendy Pan.
Related Posts:
- O’Melveny Represents China Kanghui Holdings in Agreement for Acquisition by Medtronic, Inc.
- O’Melveny Represents Financial Advisor to PLX Technology in its Acquisition by Integrated Device Technology
- O’Melveny Represents TRI Pointe Independent Directors in US$2.7 Billion Combination Transaction
- O’Melveny Represents Microsemi Corporation in Agreement to Acquire Zarlink Semiconductor, Inc.
- Akin Gump Represents True Religion in Merger Agreement with TowerBrook Partners
